Delivery Order SPE2DB20D3101-SPE2DB24FRNJ4

Award Date 6/21/24
Potential Completion Date 6/24/24
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a $10,596.30 delivery order with a firm fixed price for the supply of BREYNA 160-4.5 MCG INHALER 10.3GM to the Defense Logistics Agency (DLA). The contract has an ultimate completion date of July 15, 2024 and was awarded on July 12, 2024. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of a specific pharmaceutical product, the BREYNA 160-4.5 MCG INHALER 10.3GM, to the Defense Logistics Agency (DLA). The contract is a Delivery Order valued at $2,096.49 with a firm fixed price and a completion date of June 17, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025....
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $2,447.19 under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of a pharmaceutical product, the BREYNA 80-4.5 MCG INHALER 10.3GM, with a period of performance through December 18, 2024. The contract does not have a set-aside designation, indicating open competition. As a key vendor for...
This federal contract award, valued at $14,658.84, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The contract is for the delivery of a specific medication, BREYNA 160-4.5 MCG INHALER 10.3GM, with a completion date of July 3, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,966,027 units of the BREYNA 160-4.5 MCG INHALER 10.3GM pharmaceutical product. The contract has a ceiling value of $4,405.77 and was awarded by the Defense Logistics Agency (DLA), a defense agency, on June 21, 2024 with a completion date of June 24, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,137.45 firm fixed price delivery order is for the supply of BREYNA 160-4.5 MCG INHALER 10.3GM, a pharmaceutical product. The contract has an ultimate completion date of August 7, 2024 and was awarded on August 6, 2024. This award is likely part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,603.65, is for a Delivery Order for the BREYNA 160-4.5 MCG INHALER 10.3GM medical product. The contract has a firm fixed price and an ultimate completion date of June 27, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, is for the delivery of BREYNA 80-4.5 MCG INHALER 10.3GM medical supplies. The $3,806.90 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a part of the U.S. Department of Defense (DoD). The contract has an ultimate completion date of April 24, 2024 and is not designated as a set-aside. Amerisourcebergen holds a much...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,605.83 firm-fixed-price delivery order contract is for the supply of a BREYNA 160-4.5 MCG INHALER 10.3GM medical product, with an ultimate completion date of November 4, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of BREYNA 160-4.5 MCG INHALER 10.3GM. The $1,037.70 firm fixed-price delivery order contract has an ultimate completion date of August 9, 2024. It is not associated with any set-aside program. AmerisourceBergen, through its Corporate Office division, has been awarded multiple indefinite delivery contracts (IDCs) by the DLA Troop Support...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB24FRNJ4
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a delivery order valued at $1,532.18 for the supply of a pharmaceutical product, "BREYNA 160-4.5 MCG INHALER 10.3GM", to the Defense Logistics Agency (DLA). The contract has an ultimate completion date of June 24, 2024 and was awarded on June 21, 2024.

Amerisourcebergen, a major pharmaceutical distributor, holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle for Amerisourcebergen to provide a wide range of pharmaceutical products and medical supplies to support the Department of Defense's military treatment programs and facilities worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. This specific delivery order was not set aside for any socioeconomic program.

Generated 9/20/24, 9:13 AM